Reply SpA Stock
Price
Target price
€127.20
€127.20
-3.820%
-5.1
-3.820%
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Reply SpA Stock
Heavy losses for Reply SpA today as the stock fell by -€5.100 (-3.820%).
Pros and Cons of Reply SpA in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
B****
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Reply SpA vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Reply SpA | -3.820% | -6.813% | 2.581% | 25.444% | 6.444% | -3.196% | - |
Txt E-Solutions | -0.850% | 0.212% | 12.619% | 12.352% | 21.407% | 202.430% | - |
Exprivia | 1.250% | -3.614% | -2.736% | 24.031% | -2.439% | 39.738% | - |
Digital Turbine Inc. | -1.480% | -11.201% | -2.145% | -79.438% | -72.541% | -96.763% | - |
News
EQS-News: Reply: The Board of Directors approves the quarterly report dated 31 March 2024
EQS-News: Reply: The Board of Directors approves the quarterly report dated 31 March 2024
REPLY S.p.A.: Shareholders’ Meeting Approves the 2023 Financial Statements
The General Shareholders’ meeting of Reply S.p.A. [EXM, STAR: REY] today approved the Financial Statements for the financial year 2023, confirming the distribution of a gross dividend of €1.00 per
REPLY: Value Based Medicine Is Born, the Platform Created by Laife Reply for IEO That Makes Patient Care Increasingly Personalised and Appropriate
Laife Reply, a company within the Reply Group focused on using AI, Big Data and Machine Learning to innovate preventive healthcare and treatment processes has developed, in collaboration with IEO